No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 0.614
- +0.042+7.29%
Trading May 23 12:07 ET
43.01MMarket Cap-1979P/E (TTM)
0.630High0.591Low228.67KVolume0.600Open0.572Pre Close140.18KTurnover0.37%Turnover RatioLossP/E (Static)70.08MShares3.34052wk High-7.77P/B38.23MFloat Cap0.13452wk Low--Dividend TTM62.30MShs Float52.500Historical High--Div YieldTTM6.84%Amplitude0.134Historical Low0.613Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment With NurOwn
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel (NurOwn®).
Brainstorm Cell Therapeutics | 10-Q: Quarterly report
Express News | Brainstorm Cell Q1 2024 Adj EPS $(0.05) Beats $(0.07) Estimate
Express News | Brainstorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Express News | Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement
Express News | Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Comments
$Brainstorm Cell Therapeutics(BCLI.US$ Ya'll ready for this...🔊🎶🎶
$Brainstorm Cell Therapeutics(BCLI.US$
one could possibly read this as 1.5 million shares being shorted today. Wonder how many will lose their shorts on this one. Projected price of 2.55. Maybe I should load more.
one could possibly read this as 1.5 million shares being shorted today. Wonder how many will lose their shorts on this one. Projected price of 2.55. Maybe I should load more.
1
$Brainstorm Cell Therapeutics(BCLI.US$
BCLI Insider Trades
INSIDER NAME: Chaim Lebovits
INSIDER POSITION: President & CEO
FILING DATE: 06/05/2024 ET/
BUY/SELL: buy
STOCK/OPTION: stocks
SHARES: 66.3K
SHARES CHANGE: 6.67%
PRICE: $0.37
COST: $24,816.09
FINAL SHARE:1.06M
BCLI Insider Trades
INSIDER NAME: Chaim Lebovits
INSIDER POSITION: President & CEO
FILING DATE: 06/05/2024 ET/
BUY/SELL: buy
STOCK/OPTION: stocks
SHARES: 66.3K
SHARES CHANGE: 6.67%
PRICE: $0.37
COST: $24,816.09
FINAL SHARE:1.06M
1
$Brainstorm Cell Therapeutics(BCLI.US$ why is it going down with all the good news 🤔
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg